Target intelligence / Profile preview

Major Histocompatibility Complex Molecule (MHC)

Target
MHC
Molecular classification
MHC Class I, MHC Class II, MHC Class III, Cell surface protein, Receptor
01

Overview

The major histocompatibility complex (MHC) is a set of cell surface proteins essential for the adaptive immune system. MHC molecules bind peptide fragments derived from pathogens or self-proteins and display them on the cell surface for recognition by T cells. In humans, the MHC is referred to as the human leukocyte antigen (HLA) system. The HLA gene cluster is located on chromosome 6p21.3. There are three main classes of genes: Class I, Class II, and Class III. Class I MHC molecules present endogenous peptides to CD8+ cytotoxic T cells, while Class II MHC molecules present exogenous peptides to CD4+ helper T cells. Class III encodes complement components and cytokines; not directly involved in peptide presentation. MHC genes are highly polymorphic, ensuring broad population-level protection against pathogens but also underlying tissue transplant rejection and influencing susceptibility or resistance to autoimmune diseases.

Other names
Human Leukocyte AntigenHLA
02

Mechanism of action

MHC molecules present peptide antigens to T cells, initiating adaptive immune responses. Drugs targeting MHC indirectly modulate these responses by affecting T cell activation or antigen presentation.

03

Biological functions

Antigen presentationT cell activationAdaptive immunitySelf/non-self discriminationImmune response regulation
04

Disease associations

Autoimmune diseasesInfectionTransplant rejectionInflammation
05

Safety considerations

Immunosuppression (increased risk of infection and cancer)Graft-versus-host disease (in transplant recipients)Cytokine release syndrome
06

Interacting drugs

Immunosuppressants

3 more in the full profile.

07

Biomarkers

HLA allele typing (for transplant compatibility)MHC expression levels (in some autoimmune diseases)

Beyond the preview

Go deeper on Major Histocompatibility Complex Molecule (MHC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major Histocompatibility Complex Molecule (MHC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call